Spinal FrontiersPowered by NSpineWeekly alert sign-up
← Back

Spinal Frontiers · Regulatory Watch · FDA decision

FDA clears Solco's Blue Dolphin lumbar cage for KLIF procedures

FDA decision · Solco Biomedical (India)

6 November 2026

FDA found the 4CIS Blue Dolphin Cage System substantially equivalent under product code MAX (lumbar intervertebral fusion device used with bone graft). Solco describes it as a lumbar interbody cage designed for minimally invasive KLIF (OLLIF) procedures, already in clinical use in India, and says it may be the first such cage cleared from an Asia-based manufacturer. The FDA listing does not show the indications for use, and material and levels were not stated.

Type
FDA decision
Company
Solco Biomedical (India)
Device
4CIS Blue Dolphin Cage System
Date
6 November 2026
Jurisdiction
US
Classification
510(k) K252865 (MAX)
Source
FDA 510(k) database; SPINEMarketGroup

Official source →Source checked

Other FDA decisions

← All of Regulatory Watch

Spinal Frontiers is published by NSpine Limited, registered in England and Wales (company no. 08362634), 14 Park Row, Nottingham NG1 6GR, United Kingdom. Every item is summarised in our own words and links to its original source. Listings are a selection made at NSpine's editorial discretion and are not exhaustive; inclusion is not an endorsement, and omission implies nothing. Sponsors and advertisers have no influence on what we cover. Nothing here is medical, legal or financial advice. Spotted an error or a broken link? Email spinalfrontiers@nspine.com, or use the feedback page.

Spinal Frontiers is a trademark of NSpine GmbH.

Information only, summarised from third-party sources: not medical, legal, regulatory or financial advice. Full disclaimer.

© 2013 – 2026 NSpine Limited. Privacy notice.